Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 13 studies | 30% ± 11% | |
epithelial cell | 9 studies | 41% ± 16% | |
endothelial cell | 7 studies | 21% ± 5% | |
capillary endothelial cell | 5 studies | 18% ± 2% | |
basal cell | 4 studies | 22% ± 8% | |
respiratory goblet cell | 4 studies | 24% ± 8% | |
enterocyte | 4 studies | 31% ± 10% | |
transit amplifying cell | 4 studies | 28% ± 9% | |
placental villous trophoblast | 3 studies | 39% ± 10% | |
mucus secreting cell | 3 studies | 47% ± 16% | |
progenitor cell | 3 studies | 34% ± 10% | |
retinal rod cell | 3 studies | 22% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 5 studies | 22% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 8305.84 | 258 / 258 | 99% | 65.18 | 227 / 230 |
prostate | 99% | 2009.84 | 243 / 245 | 99% | 53.75 | 495 / 502 |
breast | 100% | 2221.38 | 459 / 459 | 93% | 19.48 | 1043 / 1118 |
skin | 98% | 2784.82 | 1781 / 1809 | 94% | 48.35 | 444 / 472 |
lung | 100% | 3030.73 | 578 / 578 | 87% | 13.69 | 1002 / 1155 |
thymus | 100% | 1124.42 | 650 / 653 | 87% | 10.01 | 526 / 605 |
esophagus | 100% | 2017.08 | 1438 / 1445 | 86% | 13.77 | 158 / 183 |
intestine | 99% | 19466.76 | 960 / 966 | 83% | 33.57 | 438 / 527 |
bladder | 100% | 1537.62 | 21 / 21 | 78% | 18.85 | 392 / 504 |
uterus | 100% | 1477.30 | 170 / 170 | 74% | 13.19 | 341 / 459 |
pancreas | 89% | 630.06 | 291 / 328 | 84% | 12.68 | 150 / 178 |
ovary | 98% | 1023.72 | 176 / 180 | 75% | 11.71 | 321 / 430 |
stomach | 85% | 657.09 | 304 / 359 | 80% | 30.89 | 228 / 286 |
kidney | 89% | 907.03 | 79 / 89 | 74% | 9.68 | 671 / 901 |
brain | 69% | 850.89 | 1817 / 2642 | 59% | 7.04 | 417 / 705 |
spleen | 100% | 979.54 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.07 | 1 / 1 |
adipose | 100% | 1890.89 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1313.13 | 1318 / 1335 | 0% | 0 | 0 / 0 |
muscle | 84% | 855.08 | 675 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 17.65 | 37 / 45 |
heart | 79% | 623.87 | 676 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 6.99 | 50 / 80 |
lymph node | 0% | 0 | 0 / 0 | 59% | 5.11 | 17 / 29 |
liver | 10% | 48.00 | 22 / 226 | 23% | 2.23 | 95 / 406 |
peripheral blood | 25% | 244.72 | 229 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019532 | Biological process | oxalate transport |
GO_0002062 | Biological process | chondrocyte differentiation |
GO_0035988 | Biological process | chondrocyte proliferation |
GO_0008272 | Biological process | sulfate transport |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_1902358 | Biological process | sulfate transmembrane transport |
GO_0001503 | Biological process | ossification |
GO_0015701 | Biological process | bicarbonate transport |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0031528 | Cellular component | microvillus membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0019531 | Molecular function | oxalate transmembrane transporter activity |
GO_0015116 | Molecular function | sulfate transmembrane transporter activity |
GO_0015106 | Molecular function | bicarbonate transmembrane transporter activity |
GO_0008271 | Molecular function | secondary active sulfate transmembrane transporter activity |
GO_0015108 | Molecular function | chloride transmembrane transporter activity |
GO_0005452 | Molecular function | solute:inorganic anion antiporter activity |
Gene name | SLC26A2 |
Protein name | Sulfate transporter (Diastrophic dysplasia protein) (Solute carrier family 26 member 2) Solute carrier family 26 member 2 |
Synonyms | DTD DTDST |
Description | FUNCTION: Sulfate transporter which mediates sulfate uptake into chondrocytes in order to maintain adequate sulfation of proteoglycans which is needed for cartilage development . Mediates electroneutral anion exchange of sulfate ions for oxalate ions and of sulfate and oxalate ions for chloride ions . Mediates exchange of sulfate and oxalate ions for hydroxyl ions and of chloride ions for bromide, iodide and nitrate ions (By similarity). The coupling of sulfate transport to both hydroxyl and chloride ions likely serves to ensure transport at both acidic pH when most sulfate uptake is mediated by sulfate-hydroxide exchange and alkaline pH when most sulfate uptake is mediated by sulfate-chloride exchange (By similarity). Essential for chondrocyte proliferation, differentiation and cell size expansion (By similarity). . |
Accessions | H0YA38 C9JAN6 ENST00000286298.5 P50443 ENST00000503336.1 ENST00000433184.1 |